Type 2 diabetes

Sleep apnoea is common among patients with type 2 diabetes.1 It is independently associated with insulin resistance, glucose intolerance and metabolic syndrome,2-4 and when untreated, can lead to poor overall treatment outcomes.

However, despite the number of type 2 diabetes patients with SDB, it largely goes undiagnosed.

Screen your patients for type 2 diabetes and SDB

As a result of accumulated research, the International Diabetes Federation recognises the association between type 2 diabetes and sleep apnoea, and recommends routinely screening OSA patients for type 2 diabetes, and screening type 2 diabetes patients displaying sleep apnoea symptoms for OSA.

And because patients with sleep apnoea and patients with diabetes share similar comorbidities, screening both ways is recommended: check for sleep apnoea in diabetes patients, and check for diabetes in patients with sleep apnoea.5

Use these helpful sleep and diagnosis resources to get your patients screened for SDB.


  • 01

    Einhorn et al. Endocr Pract. 2007

  • 02

    Aronsohn et al. Am J Respir Crit Care Med. 2010

  • 03

    Punjabi et al. Am J Respir Crit Care Med. 2002

  • 04

    Coughlin et al. Eur Heart J. 2004

  • 05

    International Diabetes Federation. The IDF consensus statement on sleep apnoea and type 2 diabetes. Brussels, Belgium: International Diabetes Federation; 2008

More SDB and chronic diseases